Outset Medical to Present at 43rd Annual Cowen Health Care Conference

SAN JOSE, Calif.--(BUSINESS WIRE)-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the 43rd Annual Cowen Health Care Conference on Wednesday, March 8, 2023 at 9:50 a.m. PT / 12:50 p.m. ET.

A live and archived webcast of the fireside chat will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230222005034/en/

Jim Mazzola
Vice President, Investor Relations
858-342-8272
[email protected]

Brian Johnston
Gilmartin Group
(332) 895-3222
[email protected]

Source: Outset Medical, Inc.

You May Also Be Interested In

• Statement from Saba Capital Management regarding Gore Street Energy Storage Fund Plc
• e.l.f. Brands Will Surprise and Delight as the Only Beauty Brand at the Minnesota State Fair
• Aker BP has started production from the Skarv Satellites